D.E. Shaw & Co’s Insmed INSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $920M | Buy |
5,625,825
+1,274,830
| +29% | +$196M | 0.55% | 17 |
|
|
2025
Q4 | $757M | Sell |
4,350,995
-1,306,469
| -23% | -$238M | 0.42% | 27 |
|
|
2025
Q3 | $815M | Buy |
5,657,464
+2,234,845
| +65% | +$274M | 0.46% | 23 |
|
|
2025
Q2 | $344M | Buy |
3,422,619
+2,687,739
| +366% | +$206M | 0.24% | 70 |
|
|
2025
Q1 | $56.1M | Buy |
734,880
+226,093
| +44% | +$17.3M | 0.05% | 438 |
|
|
2024
Q4 | $35.1M | Buy |
508,787
+442,052
| +662% | +$31.8M | 0.03% | 728 |
|
|
2024
Q3 | $4.87M | Sell |
66,735
-221,816
| -77% | -$16.4M | ﹤0.01% | 1977 |
|
|
2024
Q2 | $19.3M | Buy |
288,551
+114,529
| +66% | +$4.44M | 0.02% | 915 |
|
|
2024
Q1 | $4.72M | Sell |
174,022
-472,885
| -73% | -$13.2M | ﹤0.01% | 1928 |
|
|
2023
Q4 | $20M | Buy |
646,907
+450,180
| +229% | +$11.7M | 0.02% | 920 |
|
|
2023
Q3 | $4.97M | Buy |
196,727
+97,823
| +99% | +$2.24M | 0.01% | 1814 |
|
|
2023
Q2 | $2.09M | Sell |
98,904
-138,463
| -58% | -$2.63M | ﹤0.01% | 2597 |
|
|
2023
Q1 | $4.05M | Sell |
237,367
-189,916
| -44% | -$3.69M | ﹤0.01% | 2124 |
|
|
2022
Q4 | $8.54M | Sell |
427,283
-209,710
| -33% | -$4.05M | 0.01% | 1579 |
|
|
2022
Q3 | $13.7M | Buy |
636,993
+262,347
| +70% | +$6.29M | 0.02% | 1107 |
|
|
2022
Q2 | $7.39M | Buy |
374,646
+78,653
| +27% | +$1.65M | 0.01% | 1696 |
|
|
2022
Q1 | $6.96M | Sell |
295,993
-7,737
| -3% | -$180K | 0.01% | 1961 |
|
|
2021
Q4 | $8.27M | Sell |
303,730
-60,254
| -17% | -$1.72M | 0.01% | 1848 |
|
|
2021
Q3 | $10M | Sell |
363,984
-59,162
| -14% | -$1.55M | 0.01% | 1521 |
|
|
2021
Q2 | $12M | Sell |
423,146
-326,663
| -44% | -$9.69M | 0.01% | 1344 |
|
|
2021
Q1 | $25.5M | Sell |
749,809
-252,688
| -25% | -$9.66M | 0.02% | 800 |
|
|
2020
Q4 | $33.4M | Sell |
1,002,497
-612,553
| -38% | -$22.4M | 0.03% | 683 |
|
|
2020
Q3 | $51.9M | Sell |
1,615,050
-132,657
| -8% | -$3.81M | 0.05% | 407 |
|
|
2020
Q2 | $48.1M | Sell |
1,747,707
-489,141
| -22% | -$11.6M | 0.06% | 366 |
|
|
2020
Q1 | $35.9M | Sell |
2,236,848
-754,627
| -25% | -$17.9M | 0.06% | 380 |
|
|
2019
Q4 | $71.4M | Buy |
2,991,475
+430,169
| +17% | +$8.75M | 0.08% | 291 |
|
|
2019
Q3 | $45.2M | Buy |
2,561,306
+342,359
| +15% | +$6.61M | 0.06% | 411 |
|
|
2019
Q2 | $56.8M | Buy |
2,218,947
+1,625,381
| +274% | +$45.3M | 0.07% | 335 |
|
|
2019
Q1 | $17.3M | Buy |
593,566
+516,860
| +674% | +$13.4M | 0.02% | 797 |
|
|
2018
Q4 | $1.01M | Sell |
76,706
-71,409
| -48% | -$1.14M | ﹤0.01% | 2656 |
|
|
2018
Q3 | $3M | Sell |
148,115
-221,210
| -60% | -$5M | ﹤0.01% | 1926 |
|
|
2018
Q2 | $8.73M | Buy |
369,325
+75,347
| +26% | +$1.94M | 0.01% | 1165 |
|
|
2018
Q1 | $6.62M | Sell |
293,978
-213,347
| -42% | -$5.61M | 0.01% | 1236 |
|
|
2017
Q4 | $15.8M | Sell |
507,325
-306,237
| -38% | -$9.05M | 0.02% | 792 |
|
|
2017
Q3 | $25.4M | Buy |
813,562
+662,332
| +438% | +$12.6M | 0.04% | 520 |
|
|
2017
Q2 | $2.6M | Sell |
151,230
-4,775
| -3% | -$81.6K | ﹤0.01% | 1809 |
|
|
2017
Q1 | $2.73M | Buy |
156,005
+21,683
| +16% | +$334K | ﹤0.01% | 1650 |
|
|
2016
Q4 | $1.78M | Sell |
134,322
-60
| -0% | -$819 | ﹤0.01% | 2074 |
|
|
2016
Q3 | $1.95M | Sell |
134,382
-60,876
| -31% | -$762K | ﹤0.01% | 1943 |
|
|
2016
Q2 | $1.93M | Buy |
195,258
+72,439
| +59% | +$845K | ﹤0.01% | 1964 |
|
|
2016
Q1 | $1.56M | Sell |
122,819
-17,866
| -13% | -$235K | ﹤0.01% | 2059 |
|
|
2015
Q4 | $2.55M | Sell |
140,685
-167,327
| -54% | -$2.95M | ﹤0.01% | 1935 |
|
|
2015
Q3 | $5.72M | Buy |
308,012
+39,000
| +14% | +$973K | 0.01% | 1300 |
|
|
2015
Q2 | $6.57M | Buy |
269,012
+140,437
| +109% | +$3.19M | 0.01% | 1281 |
|
|
2015
Q1 | $2.67M | Sell |
128,575
-142,175
| -53% | -$2.5M | ﹤0.01% | 1807 |
|
|
2014
Q4 | $4.19M | Buy |
270,750
+245,580
| +976% | +$3.48M | 0.01% | 1702 |
|
|
2014
Q3 | $328K | Sell |
25,170
-182,051
| -88% | -$2.75M | ﹤0.01% | 3635 |
|
|
2014
Q2 | $4.14M | Buy |
207,221
+130,004
| +168% | +$1.93M | 0.01% | 1757 |
|
|
2014
Q1 | $1.47M | Buy |
77,217
+58,138
| +305% | +$1.1M | ﹤0.01% | 2682 |
|
|
2013
Q4 | $325K | Sell |
19,079
-9,995
| -34% | -$153K | ﹤0.01% | 4009 |
|
|
2013
Q3 | $454K | Buy |
29,074
+10,730
| +58% | +$136K | ﹤0.01% | 3645 |
|
|
2013
Q2 | $219K | Buy |
+18,344
| New | +$188K | ﹤0.01% | 3720 |
|
Other funds holding INSM
DGM
VPM
VCM
BBA
D.E. Shaw & Co's INSM Position: Q1 2026 in Review
D.E. Shaw & Co increased its Insmed (INSM) stake by 29% in Q1 2026, buying an estimated $196M and bringing the position to 5,625,825 shares worth $920M. The position accounts for 0.55% of the portfolio, ranked #17.
D.E. Shaw & Co first reported a position in INSM in Q2 2013 and has held it in 52 quarters since. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.
- D.E. Shaw & Co held 5,625,825 shares of Insmed worth $920M as of Q1 2026.
- D.E. Shaw & Co bought 1,274,830 Insmed shares in Q1 2026, an estimated $196M.
- Insmed made up 0.55% of D.E. Shaw & Co's portfolio in Q1 2026, its #17 holding.
- D.E. Shaw & Co first reported a position in Insmed in Q2 2013 and has held it in 52 quarters since.
- 669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.
Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.